Rathbones Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8K | Hold |
35,000
| – | – | ﹤0.01% | 616 |
|
|
2025
Q1 | $15.8K | Hold |
35,000
| – | – | ﹤0.01% | 596 |
|
|
2024
Q4 | $17.6K | Hold |
35,000
| – | – | ﹤0.01% | 602 |
|
|
2024
Q3 | $31.7K | Hold |
35,000
| – | – | ﹤0.01% | 594 |
|
|
2024
Q2 | $34.9K | Hold |
35,000
| – | – | ﹤0.01% | 600 |
|
|
2024
Q1 | $51.8K | Hold |
35,000
| – | – | ﹤0.01% | 591 |
|
|
2023
Q4 | $38.2K | Hold |
35,000
| – | – | ﹤0.01% | 590 |
|
|
2023
Q3 | $41.3K | Buy |
+35,000
| New | +$41.3K | ﹤0.01% | 597 |
|